Skip to main content
Download PDF

Response of Bacillus cereus ATCC 14579 to challenges with sublethal concentrations of enterocin AS-48

BMC Microbiology volume 9, Article number: 227 (2009) Cite this article

Abstract

Background

Enterocin AS-48 is produced by Enterococcus faecalis S48 to compete with other bacteria in their environment. Due to its activity against various Gram positive and some Gram negative bacteria it has clear potential for use as a food preservative. Here, we studied the effect of enterocin AS-48 challenges on vegetative cells of Bacillus cereus ATCC 14579 by use of transcriptome analysis.

Results

Of the 5200 genes analysed, expression of 24 genes was found to change significantly after a 30 min treatment with a subinhibitory bacteriocin concentration of 0.5 μg/ml. Most of up-regulated genes encode membrane-associated or secreted proteins with putative transmembrane segments or signal sequences, respectively. One operon involved in arginine metabolism was significantly downregulated. The BC4206-BC4207 operon was found to be the most upregulated target in our experiments. BC4206 codes for a PadR type transcriptional regulator, while BC4207 codes for a hypothetical membrane protein. The operon structure and genes are conserved in B. cereus and B. thuringiensis species, but are not present in B. anthracis and B. subtilis. Using real-time qPCR, we show that these genes are upregulated when we treated the cells with AS-48, but not upon nisin treatment. Upon overexpression of BC4207 in B. cereus, we observed an increased resistance against AS-48. Expression of BC4207 in B. subtilis 168, which lacks this operon also showed increased resistance against AS-48.

Conclusion

BC4207 membrane protein is involved in the resistance mechanism of B. cereus cells against AS-48.

Background

Bacillus cereus is a Gram positive rod-shaped aerobic, endospore-forming bacterium. Strains of B. cereus are widely distributed in the environment, mainly in soil, from where they easily spread to many types of foods, especially of vegetable origin, as well as meat, eggs, milk, and dairy products. This bacterium is one of the leading causes of food poisoning in the developed world. B. cereus causes two types of food-borne intoxications. One type is characterized by nausea and vomiting and abdominal cramps and has an incubation period of 1 to 6 hours. This is the "short-incubation" or emetic form of the disease. The second type is manifested primarily by abdominal cramps and diarrhea with an incubation period of 8 to 16 hours. This type is referred to as the "long-incubation" or diarrheal form of the disease [1, 2].

Different strategies may be employed to prevent B. cereus poisoning, like heating food above 75°C before use to kill vegetative cells. However, increasing trends for use of packed foods require new food preservation methods to increase the safety levels against B. cereus. One of the current approaches is the use of antimicrobial peptides (either alone or in combination with other hurdles) such as enterocin AS-48 and other bacteriocins [3–5].

Bacteriocins are small, ribosomally-synthesized antimicrobial peptides synthesized and used by one bacterium as to inhibit growth of similar or closely related bacterial strains [6]. Bacteriocins are categorized in several ways, e.g. on basis of the producing strain, common resistance mechanisms, and mechanism of killing. Enterocin AS-48 is a broad-spectrum antimicrobial peptide produced by Enterococcus faecalis S-48, belonging to Class III of enterococcal bacteriocins or enterocins [7]. Enterocin AS-48 is a 70-residue cyclic peptide with a molecular weight of 7.15 kDa [8]. The crystal structure of enterocin AS-48 has been resolved to 1.4 Ǻ resolution [9]. It is unique with respect to its natural cyclic structure in which N and C termini are linked by a peptide bond. It has been shown that enterocin AS-48 adopts different oligomeric structures according to physiochemical conditions: it exists in monomeric form at pH below 3 and in dimeric form in the pH range of 4.5 to 8.5. The molecules of AS-48 in the crystal are arranged in chains of pairs of molecules linked either by hydrophobic interactions (dimeric form I, abbreviated to DF-I), or by hydrophilic interactions (dimeric form II, abbreviated to DF-II). The molecules within the DF-I interact through the hydrophobic helices H1 and H2. On the other hand, the hydrophilic surfaces of helices H4 and H5 are interacting in DF-II.

The mode of action of enterocin AS-48 has been elucidated [10]. This bacteriocin makes pores of an approximate size of 0.7 nm in the bacterial cytoplasmic membrane thereby disrupting the proton motive force and causing cell death [10]. It also shows a secondary, bacteriolytic effect against some of the target bacteria. Based on its crystal structure, the proposed mechanism of action suggests that the two different stages of molecular association, DF-I and DF-II, are involved in changing from the water-soluble DF-I to the membrane-bound DF-II stage at the membrane surface. This transition implies a 90° rotation of each protomer within DF-I, in a way that the partially hidden hydrophobic helices H1 and H2 become solvent accessible [9]. This would permit AS-48 to insert into the bacterial membrane.

Although the mechanism of action of enterocin AS-48 has been studied extensively at physiological and physico-chemical levels, nothing is known about the responses of sensitive bacterial cells upon exposure to the bacteriocin. Previous experiment in our laboratory with AS-48 against Listeria monocytogenes showed that bacterial cells can be adapted to AS-48, thereby increasing resistance against AS-48 [11]. This adaptation can be achieved with subsequent inoculation in the presence of low, but still inhibitory concentrations of AS-48. However, the adaptation is gradually lost upon repeated subcultivation. Given the great interest of enterocin AS-48 as a food preservative, it is of high relevance to know how the target bacteria react to bacteriocin treatment. This may have direct implications on the elucidation of probable mechanisms for cell adaptation as well as the development of bacteriocin resistance mechanisms. Moreover, a better knowledge of the bacterial response to enterocin AS-48 may also allow identification of new targets that could be exploited to enhance bacteriocin activity. The purpose of the present study was to determine the genome-wide response of B. cereus cells exposed to enterocin AS-48 and to identify components that help the bacterium to survive bacteriocin treatments.

Results

Effect of enterocin AS-48 on global gene expression in B. cereus ATCC14579

Enterocin AS-48 was shown to inhibit growth of vegetative cells and spore outgrowth of B. cereus [12] and it can be an effective bioagent against B. cereus in various food related media, e.g. hard cheese, rice based foods, fruit and vegetable juices [13–15]. Although the mode of action of AS-48 is well understood, the response of bacteria to enterocin AS-48 is poorly examined. We have therefore determined the transcriptome of B. cereus ATCC14579 in response to AS-48. To omit the effect of growth inhibition related differences between the treated and the control culture, a subinhibitory bacteriocin concentration of 0.5 μg/ml of AS-48 was used in our experiments. We observed no adaptation process, when B. cereus was subsequently cultivated in the presence of 0.5 μg/ml of AS-48, but only when cells were treated with low, but inhibitory concentration of AS-48 (data not shown). In preliminary experiments samples were taken 15 and 30 min after addition of AS-48, but we could not detect any significant changes after 15 min (data not shown), therefore final transcriptome comparisons were performed on samples incubated with AS-48 for 30 min. Transcriptome analyses were performed on six independent biological replicates. 20 genes were identified to be significantly upregulated, and only 4 genes to be downregulated (Table 1). All 4 downregulated genes (BC0406-BC0409) are located in one putative operon, coding for proteins involved in arginine and proline metabolism. Most of the upregulated genes code for proteins located in the membrane (highlighted in bold in Table 1) or contain a signal sequence or periplasmic domain. The putative membrane proteins show similarity to different transport or permease proteins or have been annotated as a hypothetical protein with no known function. Two regulators belonging to the PadR family were significantly upregulated, both located upstream of, and in one operon with, genes coding for membrane proteins that are similarly enhanced during our experiments. Here, we selected the most upregulated putative operon (BC4206-4207) for further characterization. The BC4206-4207 operon is conserved in all fully sequenced B. cereus, B thuringiensis and B. weihenstephanensis genomes except in the B. cereus Cytotoxis strain, but is missing in B. anthracis and other Bacillus species. When this operon is found in a genome, the genes surrounding this operon are also conserved (Figure 1).

Table 1 Summary of transcriptional changes in B. cereus ATCC14579 upon 0.5 μg/ml AS-48 treatment
Full size table
Figure 1
figure1

Conservation of BC4206-BC4207 operon and surrounding genes in fully sequenced B. cereus, B. thuringiensis and B. weihenstephanensis species. BC4203-BC4212 numbers are depicted as genes are labelled in the genome of B. cereus ATCC14579. Arrows indicate the BC4207 homologue (in grey), PadR homologues (in black), conserved proteins with putative function: BC4203, BC4205, BC4209 and BC4210 encoding for putative hydrolase, spore lyase, lypoate-protA ligase and rhodase, respectively (dashed lined), putative conserved regulators: BC4204, BC4211 and BC4212 for putative iron dependent repressor, LacI type regulator and TetR like regulator, respectively (stripped) and other putative genes (in white).

Full size image

Validation of array experiments

Real-time RT-PCR was performed on independent samples to validate our array results. To verify that upregulation of the genes were the result of specific treatment with AS-48 and not a general response, we also applied samples that were incubated in the presence of sublethal amount of bacitracin (25 μg/ml) or nisin (2 μg/ml), bacteriocins that both affect cell wall biosynthesis through blocking the lipid II cycle by interaction with C55-isoprenyl pyrophosphate [16] or forming pores in cell membrane during interaction with lipid II [17, 18], respectively. Two genes were selected (BC4207 and BC4028), both coding for a putative membrane protein and both located downstream of a PadR like regulator (BC4206 and BC4029, respectively), for quantitative real time RT-PCR. Quantitative real time PCR showed 26 ± 6 and 18 ± 4 times upregulation of BC4207 and BC4028 in samples treated with AS-48 compared with control samples, respectively (Figure 2). Similar analysis of samples treated with AS-48 for 15 min showed less then 2 times induction of the BC4207 and BC4028 genes, in agreement with the lack of significant changes after 15 min of AS-48 treatment in microarray experiments. Samples incubated in the presence of bacitracin showed slightly enhanced expression of target genes, while addition of nisin did not significantly change the transcription of these genes.

Figure 2
figure2

RT-qPCR detection of B. cereus BC4207 and BC4028 genes. Relative expressions of BC4207 (grey bars) and BC4028 (white bars) were determined in AS-48, bacitracin and nisin treated B. cereus ATCC14579 cultures (see Methods for concentrations). Transcript levels of genes were normalized to the level of house keeping rpoA gene and compared to untreated samples (dashed line).

Full size image

Overexpression of BC4207 increases resistance against AS-48 in B. cereus and B. subtilis

To resolve whether increased expression of the putative membrane protein BC4207 helps B. cereus to defend itself against AS-48, BC4207 was cloned behind the IPTG inducible Pspac promoter and expression was induced in B. cereus ATCC14579. After preliminary induction of B. cereus containing pATK33 using 1 mM of IPTG, cells were exposed to varying amounts of AS-48 and growth was followed in time. As depicted in Table 2, cells containing overexpressed BC4207 were able to survive in the presence of slightly increased amounts of AS-48, compared to cultures containing control plasmid pLM5 or when BC4207 was not induced. Important to note is that BC4207 is already expressed in wild type B. cereus in response to AS-48 explaining the relatively low level of increased resistance upon further overexpression of BC4207. Unfortunately, we were not able to obtain a knockout of BC4207 to show the expected increased sensitivity. To support the idea that the increased resistance of B. cereus cells against AS-48 is caused by specific overexpression of the BC4207 membrane protein, we randomly selected two membrane proteins (BC4147 and BC4744) and introduced them into B. cereus ATCC14579 similar to the BC4207 protein. Expression of these proteins resulted in no significant growth difference in the presence of various amounts of AS-48 compared to the strain containing the pLM5 control plasmid. Further, comparative transcriptome analyses of B. cereus carrying pLM5 control plasmid and the BC4207 overexpressing plasmid pATK33 in the presence of IPTG revealed the significant (p-value < 10-5) upregulation of the BC4207 gene (13.6 fold) and downregulation of the BC5171 and BC5073 genes (11.6 fold and 9.3 fold, respectively), when BC4207 was expressed (data not shown). B. cereus containing pATK33 was challenged with bacitracin and nisin, but expression of BC4207 did not change the resistance of B. cereus against these bacteriocins (data not shown).

Table 2 Growth inhibition of B. cereus ATCC14579 and B. subtilis 168 strains containing BC4207 expression plasmid pATK33 or control plasmid pLM5 in the presence of various AS-48 concentrations.
Full size table

No gene coding for a BC4207 homologue can be identified in the fully sequenced genome of B. subtilis 168. BC4207 was introduced and expressed in B. subtilis with a similar method used for B. cereus. Upon induction of BC4207 the sensitivity of B. subtilis was diminished against AS-48. LiaRS was previously reported to respond to cell envelope stress and the target gene liaI was highly upregulated by LiaR in response to the addition of bacitracin or nisin to the medium [19]. To see, whether the presence of AS-48 had similar effects on the expression of the liaI gene, we have assayed the expression form liaI promoter in response to the addition of AS-48. In contrast to the high upregulation of liaI in the presence of bacitracin, we have observed no induction of expression when bacteria were incubated with various amount of AS-48 (data not shown).

Discussion

In the present study a sublethal AS-48 concentration was used to detect gene expression differences in B. cereus ATCC14579 that result from interaction of AS-48 with the cells, but not in response to cell death induced by AS-48. We aimed to determine which genes help B. cereus to survive confrontation with AS-48 and identify possible resistance mechanisms. While there was very mild change in the growth after 30 min. incubation with a sublethal bacteriocin concentration, at least 24 genes were affected significantly (Table 1). The observed changes in gene expression were mostly related to up-regulation of membrane associated or periplasmic proteins and downregulation of an operon involved in arginine/ornithine catabolism. Downregulation of argnine/ornithine metabolic genes might be related to the slight difference in growth upon AS-48 treatment that is not apparent using OD measurements. Also, this downregulation might cause a change in local pH at the cell wall in view of the decreased catabolic production of NH3 and CO2. Upregulated genes coded for hypothetical membrane proteins or putative transporters. The BC4206-BC4207 operon was most heavily upregulated in B. cereus upon AS-48 treatment. BC4206 is PadR type regulator, while BC4207 is a hypothetical membrane protein with 4 transmembrane segments. Members of the PadR family are known to have a function in regulating cellular pathways resulting in multidrug resistance, virulence or detoxification [20, 21]. These proteins involved in resistance mechanisms, are generally encoded in the vicinity of the padR genes. Overexpression of the BC4207 protein in both B. cereus and B. subtilis results in elevated resistance against AS-48. Upon overexpression of BC4207, we have found no other genes to be upregulated (data not shown), suggesting that increase in BC4207 expression alone raised the resistance of B. cereus against AS-48. Interestingly, enhanced resistance upon BC4207 overexpression was specific to enterocin AS-48 and not observed in the presence of bacitracin or nisin. Bacitracin and nisin both effect cell wall biosynthesis through blocking the lipid II cycle [16] and forming pores in the cell membrane during interaction with lipid II [17, 18], respectively. This is not the case of enterocin AS-48, since the primary action of this antimicrobial peptide, like most other bacteriocins, is the disruption of the cytoplasmic membrane.

In spite of recent advances on genome and transcriptome analysis, there are very few reports on the effects of antimicrobial substances on bacterial gene expression. Recently, Martínez et al. (2007) [22] reported that lactococcin 972 (Lcn972) significantly upregulated the expression of 26 genes in Lactococcus lactis, most of which encode membrane proteins of unknown function and the two component system (TCS) CesSR (formerly known as TCS-D) associated with cell-envelope stress. Lcn972 is a non pore-forming bacteriocin that inhibits the synthesis of peptidoglycan at the septum in Lactococcus lactis. Moreover, the response of a number of Gram-positive bacterial species towards cell wall active antibiotics has been studied recently by using genome-wide transcription analysis [19, 23–27]. Essentially, these reports describe a very complex system involving the concerted action of extracellular sigma factors and two-component systems (TCSs) [28]. LiaRS, the B. subtilis homologue of CesSR, was unable to activate liaI expression in B. subtilis in response to AS-48 treatment. Therefore, the effect of AS-48 on bacterial gene expression clearly differs from the mechanisms described earlier for B. subtilis [28].

The precise way in which BC4206 responds to the presence of AS-48 needs to be deciphered by further experimental work, including determining the target genes of BC4206 and the exact signal sensed by this PadR-type regulator. The structure and function of the BC4207 membrane protein and its role in the resistance mechanism against AS-48 is also particularly intriguing and target of our future research.

Conclusion

B. cereus cells, when treated with bacteriocin AS-48, increase the expression of the BC4207 gene coding for a putative membrane protein. Targeted inactivation of the BC4207 protein might be useful to increase the effect of AS-48 on food poisoning B. cereus cells.

Methods

Bacterial strains, growth conditions and preparation of cells for RNA isolation

Bacillus cereus ATCC 14579 and B. subtilis 168 strains from glycerol stocks were grown overnight on TY broth at 30°C, with shaking at 225 rpm. Cultures were diluted to a final OD600 of 0.15 in fresh TY medium. B. cereus ATCC14579 and B. subtilis 168 strains containing pATK33 or pLM5 were grown in the presence of 50 and 10 μg/ml of kanamycin, respectively.

Growth of B. cereus and B. subtilis in the presence of various concentration of bacteriocin was monitored every 15 minutes using a TECAN GENios Absorbance Reader (TECAN).

When cultures reached an OD600 of 0.3, purified enterocin AS-48 was added to the cultures at a concentration of 0.5 μg/ml, which was the maximal concentration not inhibiting growth, cells were harvested after 15 or 30 min by centrifugation and cell pellets were immediately frozen in liquid nitrogen and stored at -80°C until RNA isolation. Six independent biological replicates were used for microarray analysis. For quantitative RT-PCR, cells were treated with nisin and bacitracin at a subinhibitory concentration of 2 μg/ml and 25 μg/ml, respectively.

Purification of AS-48

Enterocin AS-48 was purified to homogeneity by reversed-phase high-performance chromatography as described elsewhere [29].

RNA isolation

RNA extraction was performed with the Macaloid/Roche method [30] with 2 additional steps of phenol-chloroform washing. Purified RNA concentration was measured using a Nanodrop spectrophotometer at 260 nm. The quality of purified RNA was checked with a 50 ng/μl sample by using a BioAnalyser.

DNA-microarray analysis

DNA-microarrays containing amplicons of 5200 annotated genes in the genome of B. cereus ATCC 14579 were designed and produced as described previously [31]. Slide spotting, slide treatment after spotting, and slide quality control were performed as described elsewhere [30].

Data were analysed essentially as described before [32]. Each ORF is represented by duplicate spots on the array. After hybridization, fluorescent signals were quantified with the ArrayPro analyser, and processed with Micro-Prep [31]. Statistical analysis was performed using CyberT [33]. Genes with a Bayes P-value below 1.0 × 10-4 with at least twofold differential expression were considered to be significantly affected. Microarray data has been deposited in Gene Expression Omnibus database (GSM412591).

Quantitative RT-PCR

Following RNA purification, samples were treated with RNase-free DNase I (Fermentas) for 60 min at 37°C in DNaseI buffer (10 mmol·l-1 Tris·HCl (pH7.5), 2.5 mmol·l-1 MgCl2, 0.1 mmol·l-1 CaCl2). Samples were purified with the Roche RNA isolation Kit. Reverse transcription was performed with 50 pmol random nonamers on 1 μg of total RNA using RevertAid™ H Minus M-MuLV Reverse Transcriptase (Fermentas). Quantification of cDNA was performed on an iCycler iQ (BioRad) using iQ SYBR Green Supermix. The following primers were used: for BC4207, qBCE5 (5'-GAGCAACAAATGGAAGAACTG-3') and qBCE6 (5'-TGTTTGAGTTGGTAAAGCTG-3'), for BC4028 qBCE7 (5'-CTCCATTTAATTGAGGGTGAG-3') and qBCE8 (5'-GTTTCCTGTCTATCTCTTTCCA-3') and for rpoA gene of B. cereus, qBCE3 (5'-CGTGGATATGGTACTACTTTGG-3') and qBCE4 (5'-TTCTACTACGCCCTCAACTG-3'). The amount of BC4207 and BC4028 cDNA was normalized to the level of rpoA cDNA using the 2-ΔΔCt method [34].

Overexpression of the BC4207, BC4147 and BC4744 proteins

BC4207, BC4147 and BC4744 genes were amplified with oMJGB3 (5'-GATCGAAGCTTACGGTAAATAACTTATTACAG-3') and oMJGB4 (5'-GATCCAGGCATGCTCACGTCAACAATTAACTTT-3'), oBCE9 (5'-CATATAGGAGTAATGATATG-3') and oBCE10 (5'-AGAGAAGATACGGCATAG-3'), oBCE11 (5'-TACAAGGAGTTGCTTTATGG-3') and oBCE11 (5'-TTATATCGGCGCAACTAC-3'), respectively. PCR products were cloned into the Eco47III site of pLM5 vector [35], resulting in pATK33, pATK49 and pATK411, respectively. Plasmids were introduced into the B. cereus ATCC14579 and B. subtilis 168 strains by electroporation [36] and natural transformation [37], respectively. IPTG was used at a final concentration of 1 mM to induce the overexpression of proteins.

Biological activity

Antimicrobial activities of bacteriocins were determined as minimal inhibitory concentration (MIC) values against various Bacilli following previous practice [38]. Growth was followed in the presence of various concentrations of bacteriocin and monitored every 15 minutes using a TECAN GENios Absorbance Reader (TECAN). Without bacteriocin addition, the final OD600 values were about 1.1 ± 0.1 for B. cereus, 0.8 ± 0.1 for B. subtilis. All experiments were performed in triplicate. Inhibition curves were made by plotting OD600 at the end of exponential phase in the case of the non treated strain versus bacteriocin concentration. The minimal inhibitory concentration values were determined from the inhibition curves by interpolation. The lowest concentration of bacteriocin at which less than 1% of the total increase in the OD600, measured in the absence of bacteriocin, had occurred, was taken as the MIC value. The MIC values of AS-48, nisin and bacitracin for B. cereus ATCC14579 were 2.5 μg/ml, 5 μg/ml and 50 μg/ml, respectively.

References

  1. 1.

    Granum PE, Lund T: Bacillus cereus and its food poisoning toxins. FEMS Microbiol Lett. 1997, 157: 223-228. 10.1111/j.1574-6968.1997.tb12776.x.

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Granum PE:Bacillus cereus. Food Microbiology Fundamentals and applications. Edited by: Doyle MP, Beuchat LR, Montville TJ. 2009, Washington D C, ASM Press, 373-381. 2,

    Google Scholar 

  3. 3.

    Cleveland J, Montville TJ, Nes IF, Chikindas ML: Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol. 2001, 71: 1-20. 10.1016/S0168-1605(01)00560-8.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Devlieghere F, Vermeiren L, Debevere J: New preservation technologies: Possibilities and limitations. Int Dairy J. 2004, 14: 273-285. 10.1016/j.idairyj.2003.07.002.

    Article  Google Scholar 

  5. 5.

    Galvez A, Lucas Lopez R, Abriouel H, Valdivia E, Ben Omar N: Application of bacteriocins in the control of foodborne pathogenic and spoilage bacteria. Crit Rev Biotechnol. 2008, 28: 125-152. 10.1080/07388550802107202.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Jack RW, Tagg JR, Ray B: Bacteriocins of gram-positive bacteria. Microbiol Rev. 1995, 59: 171-200.

    CAS  PubMed Central  PubMed  Google Scholar 

  7. 7.

    Franz CM, van Belkum MJ, Holzapfel WH, Abriouel H, Galvez A: Diversity of enterococcal bacteriocins and their grouping in a new classification scheme. FEMS Microbiol Rev. 2007, 31: 293-310. 10.1111/j.1574-6976.2007.00064.x.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Samyn B, Martinez-Bueno M, Devreese B, Maqueda M, Galvez A, Valdivia E, Coyette J, Van Beeumen J: The cyclic structure of the enterococcal peptide antibiotic AS-48. FEBS Lett. 1994, 352: 87-90. 10.1016/0014-5793(94)00925-2.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Sanchez-Barrena MJ, Martinez-Ripoll M, Galvez A, Valdivia E, Maqueda M, Cruz V, Albert A: Structure of bacteriocin AS-48: from soluble state to membrane bound state. J Mol Biol. 2003, 334: 541-549. 10.1016/j.jmb.2003.09.060.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Galvez A, Maqueda M, Martínez-Bueno M, Valdivia E: Permeation of bacterial cells, permeation of cytoplasmic and artificial membrane vesicles, and channel formation on lipid bilayers by peptide antibiotic AS-48. J Bacteriol. 1991, 173: 886-892.

    CAS  PubMed Central  PubMed  Google Scholar 

  11. 11.

    Mendoza F, Maqueda M, Galvez A, Martínez-Bueno M, Valdivia E: Antilisterial activity of peptide AS-48 and study of changes induced in the cell envelope properties of an AS-48-adapted strain of Listeria monocytogenes. Appl Environ Microbiol. 1999, 65: 618-625.

    CAS  PubMed Central  PubMed  Google Scholar 

  12. 12.

    Abriouel H, Maqueda M, Galvez A, Martínez-Bueno M, Valdivia E: Inhibition of bacterial growth, enterotoxin production, and spore outgrowth in strains of Bacillus cereus by bacteriocin AS-48. Appl Environ Microbiol. 2002, 68: 1473-1477. 10.1128/AEM.68.3.1473-1477.2002.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  13. 13.

    Grande MJ, Lucas R, Valdivia E, Abriouel H, Maqueda M, Ben Omar N, Martínez-Cañamero M, Gálvez A: Stability of enterocin AS-48 in fruit and vegetable juices. J Food Prot. 2005, 68: 2085-2094.

    CAS  PubMed  Google Scholar 

  14. 14.

    Grande MJ, Lucas R, Abriouel H, Valdivia E, Omar NB, Maqueda M, Martínez-Bueno M, Martínez-Cañamero M, Galvez A: Inhibition of toxicogenic Bacillus cereus in rice-based foods by enterocin AS-48. Int J Food Microbiol. 2006, 106: 185-194. 10.1016/j.ijfoodmicro.2005.08.003.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Munoz A, Maqueda M, Galvez A, Martínez-Bueno M, Rodriguez A, Valdivia E: Biocontrol of psychrotrophic enterotoxigenic Bacillus cereus in a nonfat hard cheese by an enterococcal strain-producing enterocin AS-48. J Food Prot. 2004, 67: 1517-1521.

    CAS  PubMed  Google Scholar 

  16. 16.

    Stone KJ, Strominger JL: Mechanism of action of bacitracin: complexation with metal ion and C 55 -isoprenyl pyrophosphate. Proc Natl Acad Sci USA. 1971, 68: 3223-3227. 10.1073/pnas.68.12.3223.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  17. 17.

    Breukink E, Wiedemann I, van KC, Kuipers OP, Sahl H, de KB: Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science. 1999, 286: 2361-2364. 10.1126/science.286.5448.2361.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Hasper HE, Kramer NE, Smith JL, Hillman JD, Zachariah C, Kuipers OP, de Kruijff B, Breukink E: An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science. 2006, 313: 1636-1637. 10.1126/science.1129818.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Mascher T, Margulis NG, Wang T, Ye RW, Helmann JD: Cell wall stress responses in Bacillus subtilis : the regulatory network of the bacitracin stimulon. Mol Microbiol. 2003, 50: 1591-1604. 10.1046/j.1365-2958.2003.03786.x.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Gury J, Barthelmebs L, Tran NP, Divies C, Cavin JF: Cloning, deletion, and characterization of PadR, the transcriptional repressor of the phenolic acid decarboxylase-encoding padA gene of Lactobacillus plantarum. Appl Environ Microbiol. 2004, 70: 2146-2153. 10.1128/AEM.70.4.2146-2153.2004.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  21. 21.

    Huillet E, Velge P, Vallaeys T, Pardon P: LadR, a newPadR-related transcriptional regulator from Listeria monocytogenes, negatively regulates the expression of the multidrug efflux pump MdrL. FMS Microbiol Lett. 2006, 254: 87-94. 10.1111/j.1574-6968.2005.00014.x.

    CAS  Article  Google Scholar 

  22. 22.

    Martinez B, Zomer AL, Rodriguez A, Kok J, Kuipers OP: Cell envelope stress induced by the bacteriocin Lcn972 is sensed by the Lactococcal two-component system CesSR. Mol Microbiol. 2007, 64: 473-486. 10.1111/j.1365-2958.2007.05668.x.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Cao M, Wang T, Ye R, Helmann JD: Antibiotics that inhibit cell wall biosynthesis induce expression of the Bacillus subtilis sigma(W) and sigma(M) regulons. Mol Microbiol. 2002, 45: 1267-1276. 10.1046/j.1365-2958.2002.03050.x.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Haas W, Kaushal D, Sublett J, Obert C, Tuomanen EI: Vancomycin stress response in a sensitive and a tolerant strain of Streptococcus pneumoniae. J Bacteriol. 2005, 187: 8205-8210. 10.1128/JB.187.23.8205-8210.2005.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  25. 25.

    Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K: Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 2003, 49: 807-821. 10.1046/j.1365-2958.2003.03599.x.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, Projan S, Tomasz A: Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomicin. J Bacteriol. 2006, 188: 1120-1133. 10.1128/JB.188.3.1120-1133.2006.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  27. 27.

    Utaida S, Dunman PM, Macapagal D, Murphy E, Projan SJ, Singh VK, Jayaswal RK, Wilkinson BJ: Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology. 2003, 149: 2719-2732. 10.1099/mic.0.26426-0.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    Jordan S, Hutchings MI, Mascher T: Cell envelope stress respone in Gram-positive bacteria. FEMS Microbiol Rev. 2008, 32: 107-146.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Abriouel H, Valdivia E, Martinez-Bueno M, Maqueda M, Galvez A: A simple method for semi-preparative-scale production and recovery of enterocin AS-48 derived from Enterococcus faecalis subsp. liquefaciens A-48-32. J Microbiol Methods. 2003, 55: 599-605. 10.1016/S0167-7012(03)00202-1.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    van Hijum SA, de JA, Baerends RJ, Karsens HA, Kramer NE, Larsen R, denHengst CD, Albers CJ, Kok J, Kuipers OP: A generally applicable validation scheme for the assessment of factors involved in reproducibility and quality of DNA-microarray data. BMC Genomics. 2005, 6: 77-10.1186/1471-2164-6-77.

    PubMed Central  PubMed  Article  Google Scholar 

  31. 31.

    van Hijum SA, de JA, Buist G, Kok J, Kuipers OP: UniFrag and GenomePrimer: selection of primers for genome-wide production of unique amplicons. Bioinformatics. 2003, 19: 1580-1582. 10.1093/bioinformatics/btg203.

    CAS  PubMed  Article  Google Scholar 

  32. 32.

    den Hengst CD, van Hijum SA, Geurts JM, Nauta A, Kok J, Kuipers OP: The Lactococcus lactis CodY regulon: identification of a conserved cis-regulatory element. J Biol Chem. 2005, 280: 34332-34342. 10.1074/jbc.M502349200.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Baldi P, Long AD: A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics. 2001, 17: 509-519. 10.1093/bioinformatics/17.6.509.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Marraffini LA, Schneewind O: Targeting proteins to the cell wall of sporulating Bacillus anthracis. Mol Microbiol. 2006, 6: 1402-1417. 10.1111/j.1365-2958.2006.05469.x.

    Article  Google Scholar 

  36. 36.

    Bone EJ, Ellar DJ: Transformation of Bacillus thuringiensis by electroporation. FEMS Microbiol Lett. 1989, 49: 171-177. 10.1111/j.1574-6968.1989.tb03039.x.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Venema G, Pritchard RH, Venema-Schroeder T: Fate of transforming deoxyribonucleic acid in Bacillus subtilis. J Bacteriol. 1965, 89: 1250-1255.

    CAS  PubMed Central  PubMed  Google Scholar 

  38. 38.

    Kuipers OP, Rollema HS, Yap WM, Boot HJ, Siezen RJ, de Vos WM: Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J Biol Chem. 1992, 267: 24340-24346.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Spanish Ministry of Education (research project AGL2008-01553/ALI). M.J.G. was financially supported by the Research Programme of the University of Jaén, and the Research Plan of the Junta de Andalucía (research group AGR230, project P05-AGR-107), A.T.K. by grant 818.02.004 from ALW-NWO Open programma and O.P.K. by ALW-NWO Middelgroot support. This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.

Author information

Author notes

    Affiliations

    1. Departamento de Ciencias de la Salud (Área de Microbiología), Facultad de Ciencias Experimentales, Universidad de Jaén, 23071, Jaén, Spain

      María J Grande Burgos, Hikmate Abriouel & Antonio Gálvez

    2. Department of Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Kerklaan 30, 9751NN, Haren, The Netherlands

      Ákos T Kovács, Aleksandra M Mirończuk & Oscar P Kuipers

    3. Kluyver Centre for Genomics of Industrial Fermentation, Delft/Groningen, The Netherlands

      Oscar P Kuipers

    Authors
    1. María J Grande Burgos
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Ákos T Kovács
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Aleksandra M Mirończuk
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Hikmate Abriouel
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Antonio Gálvez
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Oscar P Kuipers
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Antonio Gálvez.

    Additional information

    Authors' contributions

    MJGB and ATK contributed equally to this work. MJGB carried out the microarray experiments and wrote the manuscript, ATK performed the quantitative RT-PCRs and overexpression of BC4207 and was involved in writing the manuscript, AMM participated in the design of the growth assay and microarray experiments, AH helped to obtain the purified AS-48 bacteriocin, AG and OPK conceived and coordinated the project, and corrected the manuscript. All authors have read and approved the manuscript.

    María J Grande Burgos, Ákos T Kovács contributed equally to this work.

    Authors’ original submitted files for images

    Below are the links to the authors’ original submitted files for images.

    Authors’ original file for figure 1

    Authors’ original file for figure 2

    Rights and permissions

    Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Reprints and Permissions

    About this article

    Cite this article

    Grande Burgos, M.J., Kovács, Á.T., Mirończuk, A.M. et al. Response of Bacillus cereus ATCC 14579 to challenges with sublethal concentrations of enterocin AS-48. BMC Microbiol 9, 227 (2009). https://doi.org/10.1186/1471-2180-9-227

    Download citation

    Keywords

    • Bacitracin
    • Bacterial Gene Expression
    • Bacillus Cereus ATCC
    • Putative Membrane Protein
    • Hydrophobic Helix

    BMC Microbiology

    ISSN: 1471-2180

    Contact us